Stephanie Duatschek
CIK: 0002149575
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EBS
Emergent BioSolutions Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Duatschek Stephanie
Duatschek Stephanie (SEC CIK 0002149575) files insider reports with the SEC as EVP, CGO of Emergent BioSolutions Inc. (EBS).
Signal8 holds 1 ownership filing by Duatschek Stephanie, a Form 3, filed on Aug 12, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Duatschek Stephanie's filings is in GAITHERSBURG, MD.
Other insiders filing for Emergent BioSolutions Inc. (EBS)
- DeGolyer Donald W, Director
- Williams Paul Anthony, SVP, Products Business
- LINDAHL RICHARD S, EVP, Chief Financial Officer
- Glessner Coleen, EVP, Quality & Ethics, and CPL
- Hartzel William, SVP, Bioservices
- Dayal Sujata Tyagi, Director